Wednesday, January 10, 2018

Challenging conditions in the U.S. generic drug market have hit drugmaker Teva Pharmaceutical Industries Ltd. particularly hard.


from MarketWatch.com - Top Stories http://ift.tt/2CW3tLt

Related Posts:

  • LATEST STOCK MARKET NEWSGodrej Consumers is a 'Sell' call with a target price of Rs 650 and a stop loss of Rs 720. from Stocks-Markets-Economic Times http://bit.ly/2DGv3Mf … Read More
  • LATEST STOCK MARKET NEWSThe Nifty Realty index was trading 1.01 per cent down at 225.90 around 11:06 am. from Stocks-Markets-Economic Times http://bit.ly/2MEdWxC … Read More
  • LATEST STOCK MARKET NEWSExperts and analysts are expecting a positive set of third-quarter numbers for the power sector player. from Stocks-Markets-Economic Times http://bit.ly/2Tic1RH … Read More
  • LATEST STOCK MARKET NEWSDomestic benchmark index NSE Nifty was trading 7.20 points down at 10,645 while the BSE Sensex was trading 17.59 points up at 35,610.09. from Stocks-Markets-Economic Times http://bit.ly/2TklKHp … Read More
  • LATEST STOCK MARKET NEWSEMs are making a comeback amid optimism over easing trade tensions and less hawkish Fed. from Stocks-Markets-Economic Times http://bit.ly/2WsDn9M … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner